Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Jul 2, 2018 7:53:47 GMT -5
We have been on the market for several years now, and have had a handful of dare I say B-List celebs rave about our little darling Afrezza. We have D Dash, Lochlyn Munro, and the guy who spoke to Congress I believe, cant remember his name. But, it seems almost inevitable that someone with influence and deep pockets has to be having the same great result as Eric, Spiro, Afrezza User, etc. Aside from patient rx confidentiality, I would be curious to see who gets refills, Tom Hanks perhaps. My point being, someone who has his/her life changed in a postive way which Afrezza seems to do to its users, probably doesnt want to return to the "old" regimen of life before Afrezza. Could this a possibility for MNKD? While we continue to languish in pre $2 range the pull lower seems to be halted or at least slightly negated by unforeseen forces.
Tom are you out there?
|
|
|
Post by mnkdfann on Jul 3, 2018 10:55:04 GMT -5
While we continue to languish in pre $2 range the pull lower seems to be halted or at least slightly negated by unforeseen forces. Propped up by the powers that be until the next round of dilutive financing gets done, imo. We should know soon enough.
|
|
|
Post by harryx1 on Jul 3, 2018 10:58:27 GMT -5
|
|
|
Post by bioexec25 on Jul 3, 2018 13:24:49 GMT -5
Harryx et al, yes very happy birthday to our great nation. Thanks for your years of substantive and relevant content.
|
|
|
Post by tinkusr8215 on Jul 3, 2018 13:27:54 GMT -5
While we continue to languish in pre $2 range while the share price is $2 change, outstanding keeps going up. So you may have to look at it from different perspective - Market Cap..
$2 with 100 mil outstanding is $200 mil
$2 with 150 mil outstanding is $300 mil..
So essentially if you are still at $2 / 100 mil outstanding , in the second case , you should be thinking in terms of $3 per share...
|
|